Invalid Symbol

Stock Research for FLML

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


FLML Stock Chart & Research Data

The FLML chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the FLML chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


FLML Due diligence Resources & Stock Charts

The FLML stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View FLML Detailed Price Forecast - CNN Money CNN View FLML Detailed Summary - Google Finance
Yahoo View FLML Detailed Summary - Yahoo! Finance Zacks View FLML Stock Research & Analysis -

Stock Analysis

TradeIdeas View FLML Trends & Analysis - Trade-Ideas Barrons View FLML Major Holders - Barrons
NASDAQ View FLML Call Transcripts - NASDAQ Seeking View FLML Breaking News & Analysis - Seeking Alpha
Spotlight View FLML Annual Report - OTC Report View FLML OTC Short Report -
TradeKing View FLML Fundamentals - TradeKing Charts View FLML SEC Filings - Bar Chart
WSJ View Historical Prices for FLML - The WSJ Morningstar View Performance/Total Return for FLML - Morningstar
MarketWatch View the Analyst Estimates for FLML - MarketWatch CNBC View the Earnings History for FLML - CNBC
StockMarketWatch View the FLML Earnings - StockMarketWatch MacroAxis View FLML Buy or Sell Recommendations - MacroAxis
Bullish View the FLML Bullish Patterns - American Bulls Short Pains View FLML Short Pain Metrics -

Social Media Mentions

StockTwits View FLML Stock Mentions - StockTwits PennyStocks View FLML Stock Mentions - PennyStockTweets
Twitter View FLML Stock Mentions - Twitter Invest Hub View FLML Investment Forum News - Investor Hub
Yahoo View FLML Stock Mentions - Yahoo! Message Board Seeking Alpha View FLML Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for FLML - Insider Cow View Insider Transactions for FLML - Insider Cow
CNBC View FLML Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for FLML - OTC Markets
Yahoo View Insider Transactions for FLML - Yahoo! Finance NASDAQ View Institutional Holdings for FLML - NASDAQ

Stock Charts

FinViz View FLML Stock Insight & Charts - StockCharts View FLML Investment Charts -
BarChart View FLML Stock Overview & Charts - BarChart Trading View View FLML User Generated Charts - Trading View

Latest Financial News for FLML

Avadel Pharmaceuticals (AVDL) Looks Good: Stock Up 5.3%
Posted on Friday February 24, 2017

Avadel Pharmaceuticals plc (AVDL) shares rose over 5% in the last trading session.

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Avadel Pharmaceuticals PLC ADR
MarketWatch - Sep 24, 2017
Avadel Pharmaceuticals PLC ADR. Avadel Pharmaceuticals Plc develops and manufactures pharmaceutical products. Its hospital products include Bloxiverz, Vazculep and Akovaz.

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for FT 218 ...
Markets Insider - Jan 10, 2018
DUBLIN, Ireland, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), “Avadel” or “the Company,” today announced that FT 218 has been granted Orphan Drug Designation from the U.S.

42 Biggest Movers From Yesterday
Benzinga - Feb 15, 2018
Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares dropped 14.46 percent to close at $7.69. Avadel Pharmaceuticals reported pricing of $125.0 million 4.50 percent exchangeable senior notes due 2023.

36 Stocks Moving In Wednesday's Mid-Day Session
Benzinga - Feb 14, 2018
DBV Technologies SA - ADR (NASDAQ: DBVT) shares jumped 25.2 percent to $26.11 after the company disclosed that the U.S. FDA has agreed that the available efficacy and safety data for Viaskin Peanut supports the submission of a BLA for the treatment of ...

Enter a stock symbol to view the stock details.